Drug Truths: Dispelling the Myths about Pharma R and D / Edition 1

Paperback (Print)
Buy Used
Buy Used from BN.com
(Save 41%)
Item is in good condition but packaging may have signs of shelf wear/aging or torn packaging.
Condition: Used – Good details
Used and New from Other Sellers
Used and New from Other Sellers
from $1.99
Usually ships in 1-2 business days
(Save 93%)
Other sellers (Paperback)
  • All (13) from $1.99   
  • New (7) from $17.46   
  • Used (6) from $1.99   


This book answers the questions about the process and costs of pharmaceutical R & D in a compelling narrative focused on the discovery and development of important new medicines. It gives an insider's account of the pharmaceutical industry drug discovery process, the very real costs of misperceptions about the industry, the high stakes—both economic and scientific—of developing drugs, the triumphs that come when new compounds reach the market and save lives, and the despair that follows when new compounds fail. In the book, John LaMattina, former president of Pfizer Global Research and Development, weaves themes critical to a vital drug discovery environment in the context. This is a story that Dr. LaMattina is uniquely qualified to tell.

Read More Show Less

Editorial Reviews

From the Publisher
'This book, a concise and reasonably priced text, is a must-read for anyone working in the pharmaceutical industry. However, it is not just written for scientist, anyone interested in learning more about the big issues facing pharmaceutical research and development and global healthcare today should find this book thought-provoking.? (Pharmaceutical Journal, September 2009)

Drug Truths: Dispelling the Myths About Pharma R & D is an generally persuasive argument for the soul of the pharmaceutical industry.? (Journal of Clinical Research Best Practices, December 2009)

"I would recommend this book." (Chemistry World, June 2009)

"LaMattina stands out from many of the other observers of the industry." (Nature Chemistry, May 2009)

"The book provides unique insights into how big pharma manages its R&D. It also serves as a reminder of the useful role the drug industry play in keeping us healthy." (Chemical & Engineering News, April 20, 2009)

'The book offers an insider's account of the reality of the drug discovery process-revealing it to be more risky, complicated and expensive than many critics suggest. Chapter by chapter, LaMattina addresses the common misconceptions about the pharmaceutical industry'setting the record straight.? (Kansas City InfoZine, February 2009)

'Along with a careful dissection of each false claim and a presentation of the overwhelming evidence that disproves it, LaMattina offers fascinating explanations of the way drug development and government approval function—relying not on clever rhetoric, but on scientific fact and reliable evidence to support his claims; all the while remaining realistic about the industry's limitations.? (Medical News Today, February 2009)

"It's obvious from reading his book that LaMattina believes in his industry, in Big Pharma, and in the research and development that has led to drugs that have cured infectious diseases, delayed encroaching heart disease, controlled arthritis-for many millions-reduced pain and suffering." (TheDay.com, January 25, 2009)

Read More Show Less

Product Details

  • ISBN-13: 9780470393185
  • Publisher: Wiley
  • Publication date: 11/10/2008
  • Edition description: New Edition
  • Edition number: 1
  • Pages: 156
  • Product dimensions: 6.00 (w) x 9.20 (h) x 0.50 (d)

Meet the Author

John L. LaMattina, PhD, retired as president of Pfizer Global Research and Development in 2007 where he managed more than 13,000 scientists and support professionals in the United States, Europe, and Asia. Dr. LaMattina has received numerous awards including an Honorary Doctor of Science degree from the University of New Hampshire.

Read More Show Less

Table of Contents




Chapter 1: Cholesterol Drugs Are Unnecessary.

Chapter 2: Industry is More Interested in "Me-Too" Drugs Than in Innovation.

Chapter 3: It Takes Industry Too Long to Discover New Drugs.


Chapter 4: Drugs Are Discovered by Academia.

Chapter 5: New Medicines Add Costs but Little Benefit.

Chapter 6: Big Pharma Has Failed and Should Learn From Biotech Success.


Chapter 7: The Industry Invents Diseases.

Chapter 8: New Drugs Are Less Safe Than Traditional Medicines.

Chapter 9: Industry Spends More on Advertising Than R&D.

Chapter 10: Industry Does Not Care About Diseases of the Developing World.


Chapter 11: Big Pharma’s Day Has Passed.

Chapter 12: Final Reflections.



Read More Show Less

Customer Reviews

Average Rating 3
( 1 )
Rating Distribution

5 Star


4 Star


3 Star


2 Star


1 Star


Your Rating:

Your Name: Create a Pen Name or

Barnes & Noble.com Review Rules

Our reader reviews allow you to share your comments on titles you liked, or didn't, with others. By submitting an online review, you are representing to Barnes & Noble.com that all information contained in your review is original and accurate in all respects, and that the submission of such content by you and the posting of such content by Barnes & Noble.com does not and will not violate the rights of any third party. Please follow the rules below to help ensure that your review can be posted.

Reviews by Our Customers Under the Age of 13

We highly value and respect everyone's opinion concerning the titles we offer. However, we cannot allow persons under the age of 13 to have accounts at BN.com or to post customer reviews. Please see our Terms of Use for more details.

What to exclude from your review:

Please do not write about reviews, commentary, or information posted on the product page. If you see any errors in the information on the product page, please send us an email.

Reviews should not contain any of the following:

  • - HTML tags, profanity, obscenities, vulgarities, or comments that defame anyone
  • - Time-sensitive information such as tour dates, signings, lectures, etc.
  • - Single-word reviews. Other people will read your review to discover why you liked or didn't like the title. Be descriptive.
  • - Comments focusing on the author or that may ruin the ending for others
  • - Phone numbers, addresses, URLs
  • - Pricing and availability information or alternative ordering information
  • - Advertisements or commercial solicitation


  • - By submitting a review, you grant to Barnes & Noble.com and its sublicensees the royalty-free, perpetual, irrevocable right and license to use the review in accordance with the Barnes & Noble.com Terms of Use.
  • - Barnes & Noble.com reserves the right not to post any review -- particularly those that do not follow the terms and conditions of these Rules. Barnes & Noble.com also reserves the right to remove any review at any time without notice.
  • - See Terms of Use for other conditions and disclaimers.
Search for Products You'd Like to Recommend

Recommend other products that relate to your review. Just search for them below and share!

Create a Pen Name

Your Pen Name is your unique identity on BN.com. It will appear on the reviews you write and other website activities. Your Pen Name cannot be edited, changed or deleted once submitted.

Your Pen Name can be any combination of alphanumeric characters (plus - and _), and must be at least two characters long.

Continue Anonymously
Sort by: Showing 1 Customer Reviews
  • Posted February 10, 2009

    Where is the rest of the story?

    The author very well describes the great researchers in big pharma. However, the researchers in big pharma have the most insecure jobs. Acquisition hungry Pfizer took over Warner Lambert to obtain Lipitor, but its inventor left for another company. The author stayed at the helm only four years. It is the truth that big pharma is driven by cupidity and this is the rest of the story.

    Was this review helpful? Yes  No   Report this review
Sort by: Showing 1 Customer Reviews

If you find inappropriate content, please report it to Barnes & Noble
Why is this product inappropriate?
Comments (optional)